Title: Phase I/II Study of Volasertib (BI 6727), an Intravenous Polo-Like Kinase (Plk) Inhibitor, in Patients with Acute Myeloid Leukemia (AML): Results From the Randomized Phase II Part for Volasertib in Combination with Low-Dose Cytarabine (LDAC) Versus LDAC Monotherapy in Patients with Previously Untreated AML Ineligible for Intensive Treatment
Authors: Maertens, Johan
Luebbert, Michael
Fiedler, Walter
Fouillard, Loic
Haaland, Alf
Brandwein, Joseph M
Lepretre, Stephane
Reman, Oumedaly
Turlure, Pascal
Bug, Gesine
Mueller-Tidow, Carsten
Kraemer, Alwin
Voss, Florian
Taube, Tillmann
Fritsch, Holger
Doehner, Hartmut
Issue Date: 2012
Publisher: W.B. Saunders
Host Document: Blood vol:120 issue:21
Conference: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) location:Atlanta: GA date:DEC 08-11, 2012
ISSN: 0006-4971
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Department of Microbiology & Immunology - miscellaneous
Laboratory of Experimental Hematology (+)

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.